{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T10:54:35Z","timestamp":1793962475209,"version":"4.8.0"},"reference-count":66,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2018,11,13]],"date-time":"2018-11-13T00:00:00Z","timestamp":1542067200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine & Pharmacotherapy"],"published-print":{"date-parts":[[2019,1]]},"DOI":"10.1016\/j.biopha.2018.10.155","type":"journal-article","created":{"date-parts":[[2018,11,6]],"date-time":"2018-11-06T05:14:06Z","timestamp":1541481246000},"page":"484-492","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":141,"special_numbering":"C","title":["Reactivation of p53 gene by MDM2 inhibitors: A novel therapy for cancer treatment"],"prefix":"10.1016","volume":"109","author":[{"given":"Amit","family":"Gupta","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karan","family":"Shah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manisha J.","family":"Oza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tapan","family":"Behl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.biopha.2018.10.155_bib0005","series-title":"Burger Medicinal Chemistry and Drug Discovery","first-page":"611","author":"Wolff","year":"1994"},{"key":"10.1016\/j.biopha.2018.10.155_bib0010","doi-asserted-by":"crossref","first-page":"1969","DOI":"10.1126\/science.287.5460.1969","article-title":"Mechanism-based target identification and drug discovery in cancer research","volume":"287","author":"Gibbs","year":"2000","journal-title":"Science"},{"key":"10.1016\/j.biopha.2018.10.155_bib0015","doi-asserted-by":"crossref","first-page":"1364","DOI":"10.1016\/j.bmc.2009.11.066","article-title":"Synthesis and biological evaluation of simple methoxylated chalcones as anticancer, anti-inflammatory and antioxidant agents","volume":"18","author":"Bandgar","year":"2010","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.biopha.2018.10.155_bib0020","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1586\/era.09.12","article-title":"Genome-wide association studies: how predictable is a person\u2019s cancer risk?","author":"Roukos","year":"2009","journal-title":"Expert Rev. Anticancer Ther."},{"issue":"9","key":"10.1016\/j.biopha.2018.10.155_bib0025","doi-asserted-by":"crossref","first-page":"2097","DOI":"10.1007\/s11095-008-9661-9","article-title":"Cancer is a preventable disease that requires major lifestyle changes","volume":"25","author":"Anand","year":"2008","journal-title":"Pharm. Res."},{"key":"10.1016\/j.biopha.2018.10.155_bib0030","unstructured":"WHO calls for prevention of cancer through healthy workplaces\" (Press release). World HealthOrganization. 2007-04-27. http:\/\/www.who.int\/mediacentre\/news\/notes\/2007\/np19\/en\/index.html (Accessed 20 January 2018)."},{"issue":"Suppl 2","key":"10.1016\/j.biopha.2018.10.155_bib0035","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1016\/j.lungcan.2004.07.998","article-title":"Tobacco smoking and cancer: a brief review of recent epidemiological evidence","volume":"45","author":"Sasco","year":"2004","journal-title":"Lung Cancer (Amsterdam, Netherlands)"},{"issue":"6","key":"10.1016\/j.biopha.2018.10.155_bib0040","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1016\/j.semcancer.2004.06.009","article-title":"Infectious agents and cancer: criteria for a causal relation","volume":"14","author":"Pagano","year":"2004","journal-title":"Semin. Cancer Biol."},{"issue":"3","key":"10.1016\/j.biopha.2018.10.155_bib0045","first-page":"371","article-title":"Aetiology of cancer in Asia","volume":"9","author":"Park","year":"2008","journal-title":"Asian Pacific J. Cancer Prev."},{"key":"10.1016\/j.biopha.2018.10.155_bib0050","unstructured":"Henderson, Brian E, Leslie Bernstein, and Ronald K Ross, Chapter 13: Hormones and the Etiology of Cancer. In Bast RC, Kufe DW, Pollock RE, et al. Holland-Frei Cancer Medicine (5th ed.). Hamilton, Ontario: B.C. Decker. ISBN 1-55009-113-1. http:\/\/www.ncbi.nlm.nih.gov\/books\/NBK20759\/ (Accessed 7 January 2012)."},{"key":"10.1016\/j.biopha.2018.10.155_bib0055","doi-asserted-by":"crossref","first-page":"1","DOI":"10.4172\/1948-5956.100000e2","article-title":"History of Cancer, Ancient and modern treatment methods","volume":"1","author":"Sudhakar","year":"2009","journal-title":"J. Cancer Sci. Ther."},{"key":"10.1016\/j.biopha.2018.10.155_bib0060","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/S1368-7646(02)00119-X","article-title":"p53 as a therapeutic target: unresolved issues on the road to cancer therapy targeting mutant p53","volume":"5","author":"Fojo","year":"2002","journal-title":"Drug Resist"},{"key":"10.1016\/j.biopha.2018.10.155_bib0065","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1038\/35042675","article-title":"Surfing the p53 network","volume":"408","author":"Vogelstein","year":"2000","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.biopha.2018.10.155_bib0070","first-page":"00068","article-title":"The general information of the tumor suppressor gene p53 and the protein p53","volume":"3","author":"Zheying","year":"2015","journal-title":"J. Cancer Prev. Curr. Res."},{"key":"10.1016\/j.biopha.2018.10.155_bib0075","first-page":"1379","article-title":"Characterization of the human p53 gene","volume":"6","author":"Lamb","year":"1986","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.biopha.2018.10.155_bib0080","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1038\/320084a0","article-title":"Localization of gene for human p53 tumour antigen to band 17p13","volume":"320","author":"Isobe","year":"1986","journal-title":"Nature"},{"issue":"July(28)","key":"10.1016\/j.biopha.2018.10.155_bib0085","doi-asserted-by":"crossref","first-page":"3943","DOI":"10.1038\/onc.2016.502","article-title":"Census and evaluation of p53 target genes","volume":"36","author":"Fischer","year":"2017","journal-title":"Oncogene."},{"key":"10.1016\/j.biopha.2018.10.155_bib0090","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1038\/nrc864","article-title":"Live or let die: the cell\u2019s response to p53","author":"Vousden","year":"2002","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.biopha.2018.10.155_bib0095","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1038\/35042675","article-title":"Surfing the p53 network","volume":"408","author":"Vogelstein","year":"2000","journal-title":"Nature"},{"issue":"10","key":"10.1016\/j.biopha.2018.10.155_bib0100","doi-asserted-by":"crossref","first-page":"3705","DOI":"10.1128\/MCB.20.10.3705-3714.2000","article-title":"p53-mediated DNA repair responses to UV radiation: studies of mouse cells lacking p53, p21, and\/or gadd45 genes","author":"Smith","year":"2000","journal-title":"Mol. Cell. Biol."},{"issue":"4","key":"10.1016\/j.biopha.2018.10.155_bib0105","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1093\/emboj\/20.4.914","article-title":"A role for p53 in base excision repair","volume":"20","author":"Zhou","year":"2001","journal-title":"EMBO J."},{"issue":"1","key":"10.1016\/j.biopha.2018.10.155_bib0110","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1093\/carcin\/bgg186","article-title":"The role of p53 in base excision repair following genotoxic stress","volume":"25","author":"Zurer","year":"2004","journal-title":"Carcinogenesis"},{"issue":"1","key":"10.1016\/j.biopha.2018.10.155_bib0115","first-page":"2","article-title":"Targets of oncogenes and tumor suppressors: key for understanding basic mechanisms of carcinogenesis","volume":"65","author":"Kopnin","year":"2000","journal-title":"Biochemistry"},{"key":"10.1016\/j.biopha.2018.10.155_bib0120","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1126\/science.2683079","article-title":"Checkpoints: controls that ensure the order of cell cycle events","volume":"246","author":"Hartwell","year":"1989","journal-title":"Science"},{"issue":"23 Pt 1","key":"10.1016\/j.biopha.2018.10.155_bib0125","first-page":"6304","article-title":"Participation of p53 protein in the cellular response to DNA damage","volume":"51","author":"Kastan","year":"1991","journal-title":"Cancer Res."},{"issue":"18","key":"10.1016\/j.biopha.2018.10.155_bib0130","doi-asserted-by":"crossref","first-page":"8493","DOI":"10.1073\/pnas.92.18.8493","article-title":"p53 controls both the G2\/M and the G1 cell cycle checkpoints and mediates reversible growth arrest in human fibroblasts","volume":"92","author":"Agarwal","year":"1995","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.biopha.2018.10.155_bib0135","unstructured":"el-Deiry, W. S., J. W. Harper, P. M. O\u2019Connor, V. E. Velculescu, C. E. Canman, J. Jackman, J. A. Pietenpol, M. Burrell, D. E. Hill, Y. Wang and et al. (1994) WAF1\/CIP1 is induced in p53-mediated G1 arrest and apoptosis. Cancer Res. 1994, 54(5):1169-1174."},{"issue":"8","key":"10.1016\/j.biopha.2018.10.155_bib0140","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1101\/gad.9.8.935","article-title":"p53-dependent and independent expression of p21 during cell growth, differentiation, and DNA damage","volume":"9","author":"Macleod","year":"1995","journal-title":"Genes Dev."},{"issue":"31","key":"10.1016\/j.biopha.2018.10.155_bib0145","doi-asserted-by":"crossref","first-page":"29116","DOI":"10.1074\/jbc.M104130200","article-title":"Sp1 plays a critical role in the transcriptional activation of the human cyclindependent kinase inhibitor p21 (WAF1\/Cip1) gene by the p53 tumor suppressor protein","volume":"276","author":"Koutsodontis","year":"2001","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.biopha.2018.10.155_bib0150","doi-asserted-by":"crossref","first-page":"19205","DOI":"10.1074\/jbc.M009528200","article-title":"p53 displacement from centrosomes and p53-mediated G1 arrest following transient inhibition of the mitotic spindle","volume":"276","author":"Ciciarello","year":"2001","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.biopha.2018.10.155_bib0155","doi-asserted-by":"crossref","first-page":"4077","DOI":"10.1242\/jcs.00739","article-title":"Apoptosis - the p53 network","volume":"116","author":"Haupt","year":"2003","journal-title":"J. Cell. Sci."},{"key":"10.1016\/j.biopha.2018.10.155_bib0160","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1126\/science.288.5468.1053","article-title":"A BH3-only member of the Bcl-2 family and candidate mediator of p53-induced apoptosis","volume":"288","author":"Oda","year":"2000","journal-title":"Science"},{"key":"10.1016\/j.biopha.2018.10.155_bib0165","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1016\/S1097-2765(01)00214-3","article-title":"A novel proapoptotic gene, is induced by p53","volume":"7","author":"Nakano","year":"2001","journal-title":"Mol. Cell"},{"key":"10.1016\/j.biopha.2018.10.155_bib0170","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1038\/ncb866","article-title":"BID regulation by p53 contributes to chemosensitivity","volume":"4","author":"Sax","year":"2002","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.biopha.2018.10.155_bib0175","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1016\/j.bbabio.2008.10.005","article-title":"The mitochondrial p53 pathway","volume":"1787","author":"Vaseva","year":"2009","journal-title":"Biochim. Biophys. Acta"},{"issue":"4","key":"10.1016\/j.biopha.2018.10.155_bib0180","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/S1535-6108(03)00244-7","article-title":"Puma is an essential mediator of p53-dependent and -independent apoptotic pathways","volume":"4","author":"Jeffers","year":"2003","journal-title":"Cancer Cell"},{"issue":"5387","key":"10.1016\/j.biopha.2018.10.155_bib0185","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1126\/science.282.5387.290","article-title":"Cell surface trafficking of Fas: a rapid mechanism of p53-mediated apoptosis","volume":"282","author":"Bennett","year":"1998","journal-title":"Science"},{"issue":"10","key":"10.1016\/j.biopha.2018.10.155_bib0190","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.1002\/j.1460-2075.1991.tb07676.x","article-title":"Tumorigenic potential associated with enhanced expression of a gene that is amplified in a mouse tumour cell line","volume":"1991","author":"Fakharzadeh","year":"1991","journal-title":"EMBO J."},{"key":"10.1016\/j.biopha.2018.10.155_bib0195","doi-asserted-by":"crossref","first-page":"1596","DOI":"10.1002\/j.1460-2075.1996.tb00504.x","article-title":"Cell type-specific inhibition of p53-mediated apoptosis by mdm2","volume":"15","author":"Haupt","year":"1996","journal-title":"EMBO J."},{"key":"10.1016\/j.biopha.2018.10.155_bib0200","doi-asserted-by":"crossref","first-page":"3023","DOI":"10.1128\/MCB.20.6.2023-2030.2000","article-title":"The p53 tumor suppressor protein does not regulate expression of its own inhibitor, MDM2, except under conditions of stress","volume":"20","author":"Mendrysa","year":"2000","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.biopha.2018.10.155_bib0205","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/S0378-1119(99)00487-4","article-title":"MDM2\u2013master regulator of the p53 tumor suppressor protein","volume":"242","author":"Momand","year":"2000","journal-title":"Gene"},{"issue":"3","key":"10.1016\/j.biopha.2018.10.155_bib0210","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1007\/BF01535205","article-title":"Molecular analysis and chromosomal mapping of amplified genes isolated from a transformed mouse 3T3 cell line","volume":"13","author":"Cahilly-Snyder","year":"1987","journal-title":"Somat. Cell Mol. Genet."},{"key":"10.1016\/j.biopha.2018.10.155_bib0215","first-page":"993","article-title":"MDM2, an introduction","volume":"1","author":"Iwakuma","year":"2003","journal-title":"Mol. Cancer Res."},{"issue":"7","key":"10.1016\/j.biopha.2018.10.155_bib0220","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1016\/0092-8674(92)90644-R","article-title":"The mdm-2 oncogene product forms a complex with the p53 protein and inhibits p53-mediated transactivation","volume":"69","author":"Momand","year":"1992","journal-title":"Cell"},{"issue":"6630","key":"10.1016\/j.biopha.2018.10.155_bib0225","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1038\/387296a0","article-title":"Mdm2 promotes the rapid degradation of p53","volume":"387","author":"Haupt","year":"1997","journal-title":"Nature"},{"issue":"7","key":"10.1016\/j.biopha.2018.10.155_bib0230","first-page":"1275","article-title":"N-terminal 130 amino acids of MDM2 are sufficient to inhibit p53-mediated transcriptional activation","volume":"10","author":"Leng","year":"1995","journal-title":"Oncogene"},{"issue":"12","key":"10.1016\/j.biopha.2018.10.155_bib0235","doi-asserted-by":"crossref","first-page":"8945","DOI":"10.1074\/jbc.275.12.8945","article-title":"Mdm2 is a RING finger-dependent ubiquitin protein ligase for itself and p53","volume":"275","author":"Fang","year":"2000","journal-title":"J. Biol. Chem."},{"issue":"11","key":"10.1016\/j.biopha.2018.10.155_bib0240","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.1038\/sj.onc.1203464","article-title":"Activity of MDM2, a ubiquitin ligase, toward p53 or itself is dependent on the RING finger domain of the ligase","volume":"19","author":"Honda","year":"2000","journal-title":"Oncogene"},{"issue":"24","key":"10.1016\/j.biopha.2018.10.155_bib0245","doi-asserted-by":"crossref","first-page":"11623","DOI":"10.1073\/pnas.90.24.11623","article-title":"The mdm-2 gene is induced in response to UV light in a p53-dependent manner","volume":"90","author":"Perry","year":"1993","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"4","key":"10.1016\/j.biopha.2018.10.155_bib0250","first-page":"896","article-title":"DNA damage increases the levels of MDM2 messenger RNA in wtp53 human cells","volume":"54","author":"Price","year":"1994","journal-title":"Cancer Res."},{"issue":"2","key":"10.1016\/j.biopha.2018.10.155_bib0255","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1006\/excr.1995.1120","article-title":"Induction of p53-, MDM2-, and WAF1\/CIP1-like molecules in insect cells by DNA-damaging agents","volume":"217","author":"Bae","year":"1995","journal-title":"Exp. Cell Res."},{"key":"10.1016\/j.biopha.2018.10.155_bib0260","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/S0092-8674(03)00193-4","article-title":"Pirh2, a p53-Induced Ubiquitin-Protein Ligase, Promotes p53 Degradation\u201d Cell press","volume":"112","author":"Leng","year":"2003","journal-title":"Cell"},{"issue":"4","key":"10.1016\/j.biopha.2018.10.155_bib0265","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1172\/JCI45784","article-title":"Cop1 constitutively regulates c-Jun protein stability and functions as a tumor suppressor in mice\u201d","volume":"121","author":"Migliorini","year":"2011","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.biopha.2018.10.155_bib0270","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1016\/S0092-8674(00)80452-3","article-title":"Tumor suppression at the mouse INK4a locus mediated by the alternative reading frame product p19ARF","volume":"91","author":"Kamijo","year":"1997","journal-title":"Cell"},{"key":"10.1016\/j.biopha.2018.10.155_bib0275","doi-asserted-by":"crossref","first-page":"2358","DOI":"10.1101\/gad.827300","article-title":"p53-Independent functions of the p19(ARF) tumor suppressor","volume":"14","author":"Weber","year":"2000","journal-title":"Genes Dev."},{"key":"10.1016\/j.biopha.2018.10.155_bib0280","first-page":"3145","article-title":"The alternative reading frame tumor suppressor inhibits growth through p21-dependent and p21-independent pathways","volume":"61","author":"Modestou","year":"2001","journal-title":"Cancer Res."},{"key":"10.1016\/j.biopha.2018.10.155_bib0285","doi-asserted-by":"crossref","first-page":"7118","DOI":"10.1074\/jbc.M412330200","article-title":"p14ARF induces G2 cell cycle arrest in p53- and p21-deficient cells by down-regulating p34cdc2 kinase activity","volume":"280","author":"Normand","year":"2005","journal-title":"J. Biol. Chem."},{"issue":"February(2)","key":"10.1016\/j.biopha.2018.10.155_bib0290","first-page":"173","article-title":"Nutlin-3, a p53-Mdm2 antagonist for nasopharyngeal carcinoma treatment","volume":"18","author":"Yee-Lin","year":"2018","journal-title":"Mini Rev. Med. Chem."},{"issue":"10","key":"10.1016\/j.biopha.2018.10.155_bib0295","doi-asserted-by":"crossref","first-page":"3933","DOI":"10.1073\/pnas.0708917105","article-title":"Temporal activation of p53 by a specific MDM2 inhibitor is selectively toxic to tumors and leads to complete tumor growth inhibition","volume":"105","author":"Shangary","year":"2008","journal-title":"J. PNAS"},{"issue":"9","key":"10.1016\/j.biopha.2018.10.155_bib0300","first-page":"3321","article-title":"Efficacy of MDM2 inhibitor MI-219 against lung cancer cells alone or in combination with MDM2 knockdown, a XIAP inhibitor or etoposide","volume":"30","author":"zheng","year":"2010","journal-title":"J. Int. J. Cancer Res. Treat."},{"key":"10.1016\/j.biopha.2018.10.155_bib0305","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1186\/1476-4598-8-115","volume":"8","author":"Mohammad","year":"2009","journal-title":"J. Mol. Cancer"},{"issue":"6","key":"10.1016\/j.biopha.2018.10.155_bib0310","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1016\/j.ejca.2010.01.015","article-title":"Mohammad. MDM2 inhibitor MI-319 in combination with cisplatin is an effective treatment for pancreatic cancer independent of p53 function","volume":"46","author":"Azmi","year":"2010","journal-title":"J. Eur. J. Cancer"},{"key":"10.1016\/j.biopha.2018.10.155_bib0315","doi-asserted-by":"crossref","first-page":"14734","DOI":"10.1073\/pnas.212428599","article-title":"Differentiation of Hdm2-mediated p53 ubiquitination and Hdm2 autoubiquitination activity by small molecular weight inhibitors","volume":"99","author":"Lai","year":"2002","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.biopha.2018.10.155_bib0320","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1177\/1087057104267956","article-title":"Assay for ubiquitin ligase activity: high-throughput screen for inhibitors of HDM2","volume":"9","author":"Davydov","year":"2004","journal-title":"J. Biomol. Screen."},{"issue":"July(7)","key":"10.1016\/j.biopha.2018.10.155_bib0325","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1007\/s10495-014-0990-3","article-title":"Small molecule compounds targeting the p53 pathway: are we finally making progress?","volume":"1","author":"Yu","year":"2014","journal-title":"Apoptosis"},{"issue":"16","key":"10.1016\/j.biopha.2018.10.155_bib0330","article-title":"Novel targeted therapeutics: inhibitors of MDM2, ALK and PARP","volume":"4","author":"Yuan","year":"2011","journal-title":"J. Hematol. Oncol."}],"container-title":["Biomedicine & Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S075333221835296X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S075333221835296X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,4]],"date-time":"2026-05-04T06:45:17Z","timestamp":1777877117000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S075333221835296X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,1]]},"references-count":66,"alternative-id":["S075333221835296X"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2018.10.155","relation":{},"ISSN":["0753-3322"],"issn-type":[{"value":"0753-3322","type":"print"}],"subject":[],"published":{"date-parts":[[2019,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Reactivation of p53 gene by MDM2 inhibitors: A novel therapy for cancer treatment","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2018.10.155","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Masson SAS.","name":"copyright","label":"Copyright"}]}}